Suppr超能文献

接受远程医疗服务治疗阿片类药物使用障碍的患者的观点:用户体验的定性分析。

Perspectives of Patients Receiving Telemedicine Services for Opioid Use Disorder Treatment: A Qualitative Analysis of User Experiences.

机构信息

From the RAND Corporation, Boston, MA (JLS); Greater Los Angeles VA Medical Center, Los Angeles, CA (PR); Harvard Medical School, Boston, MA (HAH, AM, ABB); Beth Israel Deaconess Medical Center, Boston, MA (AM); McLean Hospital, Belmont, MA (ABB); Harvard T. H. Chan School of Public Health, Boston, MA (MLB); RAND Corporation, Arlington, VA (LU-P).

出版信息

J Addict Med. 2022;16(6):702-708. doi: 10.1097/ADM.0000000000001006. Epub 2022 Jul 20.

Abstract

OBJECTIVE

Telemedicine for opioid use disorder (tele-OUD) has the potential to increase access to medications for OUD (MOUD). Fully virtual tele-OUD services, in which all care is provided via telemedicine, are increasingly common, yet few studies document the experiences of patients who use such services. Understanding patient perspectives is one of multiple considerations to inform the regulation and reimbursement of tele-OUD services.

METHODS

We conducted semi-structured interviews with 20 adults receiving care from one fully virtual tele-OUD service who had received 3 to 5 weeks of treatment. Analyses were conducted using an inductive and deductive approach informed by the modified Unified Theory of Acceptance and Use of Technology model.

RESULTS

Over three quarters of patients with past experience receiving in-person MOUD treatment described tele-OUD as more advantageous with its key strength being more patient centered. Over three quarters of patients said they felt tele-OUD helped to ameliorate social barriers to seeking treatment, and nearly all said they appreciated the speed at which they were able to initiate MOUD treatment via tele-OUD. Surprisingly, the pandemic was not among the factors that influenced patient interest in tele-OUD.

CONCLUSIONS

Patients engaged in one fully virtual tele-OUD service described unique advantages of tele-OUD. More research is needed to determine the appropriateness of tele-OUD for people in various stages of recovery, and data on long-term treatment outcomes are needed to inform decisions regarding the regulation and reimbursement of fully virtual and hybrid care models for OUD.

摘要

目的

远程医疗治疗阿片类药物使用障碍(远程 OUD)有可能增加获得 OUD 药物治疗(MOUD)的机会。完全虚拟的远程 OUD 服务,即所有护理均通过远程医疗提供,越来越常见,但很少有研究记录使用此类服务的患者的体验。了解患者的观点是为远程 OUD 服务提供监管和报销提供信息的多个考虑因素之一。

方法

我们对 20 名正在接受一家完全虚拟的远程 OUD 服务的成年人进行了半结构化访谈,这些患者接受了 3 至 5 周的治疗。分析采用了基于修正的统一技术接受和使用理论的归纳和演绎方法。

结果

超过四分之三有过接受面对面 MOUD 治疗经历的患者表示,远程 OUD 更具优势,其主要优势在于更以患者为中心。超过四分之三的患者表示,他们认为远程 OUD 有助于缓解寻求治疗的社会障碍,几乎所有人都表示他们赞赏通过远程 OUD 能够如此迅速地开始 MOUD 治疗。令人惊讶的是,大流行并不是影响患者对远程 OUD 兴趣的因素之一。

结论

参与一家完全虚拟的远程 OUD 服务的患者描述了远程 OUD 的独特优势。需要进一步研究以确定远程 OUD 对于处于不同康复阶段的人群是否合适,并且需要关于长期治疗结果的数据,以告知有关 OUD 的完全虚拟和混合护理模式的监管和报销决策。

相似文献

2
Health center implementation of telemedicine for opioid use disorders: A qualitative assessment of adopters and nonadopters.
J Subst Abuse Treat. 2020 Aug;115:108037. doi: 10.1016/j.jsat.2020.108037. Epub 2020 May 13.
3
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19.
J Addict Med. 2023;17(2):e110-e118. doi: 10.1097/ADM.0000000000001079. Epub 2022 Sep 19.
4
Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
Subst Abus. 2022;43(1):39-46. doi: 10.1080/08897077.2020.1728466. Epub 2020 Feb 20.
6
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.
J Subst Abuse Treat. 2022 Aug;139:108777. doi: 10.1016/j.jsat.2022.108777. Epub 2022 Mar 25.
7
Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
JAMA Netw Open. 2023 Oct 2;6(10):e2336914. doi: 10.1001/jamanetworkopen.2023.36914.
8
Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder.
J Subst Abuse Treat. 2022 Feb;133:108492. doi: 10.1016/j.jsat.2021.108492. Epub 2021 May 28.
9
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
J Subst Abuse Treat. 2021 Mar;122:108196. doi: 10.1016/j.jsat.2020.108196. Epub 2020 Nov 14.
10
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
J Subst Abuse Treat. 2020 Nov;118:108124. doi: 10.1016/j.jsat.2020.108124. Epub 2020 Aug 30.

引用本文的文献

3
Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review.
Drug Alcohol Depend. 2025 Jan 1;266:112522. doi: 10.1016/j.drugalcdep.2024.112522. Epub 2024 Dec 4.
4
Patient satisfaction with telemedicine for substance-related disorders.
Digit Health. 2024 Aug 5;10:20552076241240974. doi: 10.1177/20552076241240974. eCollection 2024 Jan-Dec.
7
Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.
Drug Alcohol Depend. 2024 Jun 1;259:111290. doi: 10.1016/j.drugalcdep.2024.111290. Epub 2024 Apr 16.
8
Patients' and Clinicians' Experiences with In-person, Video, and Phone Modalities for Opioid Use Disorder Treatment: A Qualitative Study.
J Gen Intern Med. 2024 Sep;39(12):2179-2186. doi: 10.1007/s11606-023-08586-6. Epub 2024 Jan 16.
9
Choosing Or Losing In Behavioral Health: A Study Of Patients' Experiences Selecting Telehealth Versus In-Person Care.
Health Aff (Millwood). 2023 Sep;42(9):1275-1282. doi: 10.1377/hlthaff.2023.00487.
10
Service users' perception and attitude toward telemedicine-based treatment for substance use disorders: A qualitative study from India.
Indian J Psychiatry. 2023 Jul;65(7):774-784. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_167_23. Epub 2023 Jul 12.

本文引用的文献

2
Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study.
J Subst Abuse Treat. 2021 May;124:108288. doi: 10.1016/j.jsat.2021.108288. Epub 2021 Jan 13.
3
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
Subst Abus. 2021;42(2):205-212. doi: 10.1080/08897077.2021.1890676. Epub 2021 Mar 8.
6
Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review.
J Addict Med. 2021;15(1):74-84. doi: 10.1097/ADM.0000000000000739.
7
Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine.
J Subst Abuse Treat. 2020 Nov;118:108124. doi: 10.1016/j.jsat.2020.108124. Epub 2020 Aug 30.
8
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update.
J Addict Med. 2020 Mar/Apr;14(2S Suppl 1):1-91. doi: 10.1097/ADM.0000000000000633.
9
Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model.
JAMA. 2020 Jul 7;324(1):39-40. doi: 10.1001/jama.2020.3940.
10
Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
Subst Abus. 2022;43(1):39-46. doi: 10.1080/08897077.2020.1728466. Epub 2020 Feb 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验